Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Gene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cells.

Pei N, Jie F, Luo J, Wan R, Zhang Y, Chen X, Liang Z, Du H, Li A, Chen B, Zhang Y, Sumners C, Li J, Gu W, Li H.

PLoS One. 2014 Mar 21;9(3):e92253. doi: 10.1371/journal.pone.0092253. eCollection 2014.

PMID:
24658029
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.

Li H, Qi Y, Li C, Braseth LN, Gao Y, Shabashvili AE, Katovich MJ, Sumners C.

Mol Cancer Ther. 2009 Dec;8(12):3255-65. doi: 10.1158/1535-7163.MCT-09-0237. Epub .

PMID:
19996275
[PubMed - indexed for MEDLINE]
Free Article
3.

Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo.

Du H, Liang Z, Zhang Y, Jie F, Li J, Fei Y, Huang Z, Pei N, Wang S, Li A, Chen B, Zhang Y, Sumners C, Li M, Li H.

PLoS One. 2013 Dec 31;8(12):e83754. doi: 10.1371/journal.pone.0083754. eCollection 2013.

PMID:
24391821
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.

Wang X, Khaidakov M, Ding Z, Mitra S, Lu J, Liu S, Mehta JL.

Exp Biol Med (Maywood). 2012 Dec;237(12):1394-401. doi: 10.1258/ebm.2012.012212.

PMID:
23354398
[PubMed - indexed for MEDLINE]
5.

Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.

Guimond MO, Battista MC, Nikjouitavabi F, Carmel M, Barres V, Doueik AA, Fazli L, Gleave M, Sabbagh R, Gallo-Payet N.

Prostate. 2013 Jul;73(10):1057-68. doi: 10.1002/pros.22653. Epub 2013 Feb 6.

PMID:
23389987
[PubMed - indexed for MEDLINE]
6.

Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.

Bose SK, Gibson W, Giri S, Nath N, Donald CD.

Prostate. 2009 Sep 1;69(12):1334-42. doi: 10.1002/pros.20980.

PMID:
19517575
[PubMed - indexed for MEDLINE]
7.

Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury.

Qi Y, Li H, Shenoy V, Li Q, Wong F, Zhang L, Raizada MK, Sumners C, Katovich MJ.

Exp Physiol. 2012 Jan;97(1):89-101. doi: 10.1113/expphysiol.2011.060673. Epub 2011 Oct 3.

PMID:
21967903
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.

Chan LY, Leung JC, Tang SC, Choy CB, Lai KN.

J Am Soc Nephrol. 2005 Aug;16(8):2306-17. Epub 2005 Jun 1.

PMID:
15930094
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.

Grzmil M, Thelen P, Hemmerlein B, Schweyer S, Voigt S, Mury D, Burfeind P.

Am J Pathol. 2003 Aug;163(2):543-52.

PMID:
12875974
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The functional significance of microRNA-145 in prostate cancer.

Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, Saini S, Majid S, Liu J, Khatri G, Tanaka Y, Dahiya R.

Br J Cancer. 2010 Jul 13;103(2):256-64. doi: 10.1038/sj.bjc.6605742. Epub 2010 Jun 29. Erratum in: Br J Cancer. 2011 Mar 1;104(5):892.

PMID:
20588276
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread.

Carl-McGrath S, Ebert MP, Lendeckel U, Röcken C.

Cancer Biol Ther. 2007 Aug;6(8):1218-26. Epub 2007 Aug 10.

PMID:
18059164
[PubMed - indexed for MEDLINE]
Free Article
13.

Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis.

Wang X, Lu J, Khaidakov M, Mitra S, Ding Z, Goyal T, Mehta JL.

Apoptosis. 2012 Aug;17(8):908-15. doi: 10.1007/s10495-012-0721-6.

PMID:
22527949
[PubMed - indexed for MEDLINE]
14.

Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.

Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.

Mol Cancer Res. 2008 Dec;6(12):1852-60. doi: 10.1158/1541-7786.MCR-08-0012.

PMID:
19074830
[PubMed - indexed for MEDLINE]
Free Article
15.

Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.

Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.

Cancer Res. 2005 Jul 15;65(14):6364-70.

PMID:
16024639
[PubMed - indexed for MEDLINE]
Free Article
16.

Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.

Festuccia C, Gravina GL, D'Alessandro AM, Millimaggi D, Di Rocco C, Dolo V, Ricevuto E, Vicentini C, Bologna M.

Int J Oncol. 2008 Aug;33(2):381-8.

PMID:
18636160
[PubMed - indexed for MEDLINE]
17.

Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.

Wang BD, Kline CL, Pastor DM, Olson TL, Frank B, Luu T, Sharma AK, Robertson G, Weirauch MT, Patierno SR, Stuart JM, Irby RB, Lee NH.

Mol Cancer. 2010 Apr 30;9:98. doi: 10.1186/1476-4598-9-98.

PMID:
20433755
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells.

Chang I, Majid S, Saini S, Zaman MS, Yamamura S, Chiyomaru T, Shahryari V, Fukuhara S, Deng G, Dahiya R, Tanaka Y.

Mol Cancer Ther. 2013 Jun;12(6):1049-59. doi: 10.1158/1535-7163.MCT-12-1187. Epub 2013 Apr 11.

PMID:
23580416
[PubMed - indexed for MEDLINE]
Free Article
19.

Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.

Sanlioglu AD, Koksal IT, Karacay B, Baykara M, Luleci G, Sanlioglu S.

Cancer Gene Ther. 2006 Jan 1;13(1):21-31.

PMID:
16052230
[PubMed - indexed for MEDLINE]
20.

DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells.

Sanlioglu AD, Karacay B, Koksal IT, Griffith TS, Sanlioglu S.

Cancer Gene Ther. 2007 Dec;14(12):976-84. Epub 2007 Sep 14.

PMID:
17853923
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk